Loading stock data…
$10.70+0.03 (+0.28%)
Oaktree Acquisition Corp.
Oaktree Acquisition Corp. III Life Sciences in the Financial Services sector is trading at $10.70 with a market capitalization of $262M. The stock is currently near its 52-week high of $10.74, remaining 0.8% above its 200-day moving average. On fundamentals, Piotroski 2/9 flags weak fundamentals, Altman Z in the safe zone. The Whystock Score of 80/100 reflects bullish alignment across trend, valuation and analyst targets.
| Metric (USD) | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|---|
| Total Revenue | $0 | $0 | $0 | $0 | $0 |
| Gross Profit | — | — | — | — | — |
| Operating Income | -$456,538↓ | -$255,496↓ | -$225,579↑ | -$269,810↑ | -$444,802 |
| Net Income | $1.39M↓ | $1.79M↓ | $1.97M↑ | $1.87M↑ | $1.66M |
Oaktree Acquisition Corp. III Life Sciences does not have significant operations. The company focuses on effecting a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesse...